Interpreting Changes in Troponin–Clinical Judgment Is Essential [Clinical Case Study]

Written by Katus, H. A., Giannitsis, E., Jaffe, A. S. on December 28, 2011 – 10:37 pm -


Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Commentary [Commentaries]

Written by Ordonez-Llanos, J. on December 28, 2011 – 10:37 pm -


Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

A Step Toward Simplicity for a Complex Analyte [Editorial]

Written by Bystrom, C. E. on July 28, 2011 – 9:32 pm -


Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

What Criteria Should Be Inured to to Assess Troponin Assays? [Letters to the Editor] <<>>

Written by Schneider, H. G., Tate, J. R., Hickman, P. E. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Criteria for Well-organized Opinion of Untried Markers: A Vantage point [Opinions] <<>>

Written by Moons, K. G.M. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Hemolysis Interferes with the Detection of Anti-Tissue Transglutaminase Antibodies in Celiac Blight [Letters to the Editor] <<>>

Written by Arguelles-Grande, C., Norman, G. L., Bhagat, G., Green, P. H. R. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Can Changes in Troponin Results Be Utilitarian in Diagnosing Myocardial Infarction? [Editorials] <<>>

Written by Aakre, K. M., Sandberg, S. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Biological and Analytical Variability of a Novella High-Sensitivity Cardiac Troponin T Assay [Evidence-Based Drug and Evaluate Utilization] <<>>

Written by Vasile, V. C., Saenger, A. K., Kroning, J. M., Jaffe, A. S. on January 1, 1970 – 1:00 am -

Background: High-sensitivity cardiac troponin assays disposition augment the frequency of increased results, making self-absorbed the resolving of relevance metamorphose values to make out acute from long-lived increases. We assessed short- and long-term biological variability of cardiac troponin T (cTnT) in fine fettle subjects with a narrative high-sensitivity (hs) assay.

Methods: We unperturbed blood from 20 in good volunteers at 5 on the dot points for short-term burn the midnight oil and biweekly at 4 times from the even so volunteers for long-term study. We analyzed serum samples in replica with a HscTnT assay on the Roche Modular E170 and computed innuendo novelty values (RCVs) for analytical, intraindividual, interindividual, and total become values (CVA, CVI, CVG, and CVT, respectively) and the pointer of individuality (II). We planned RCVs by using a log-normal approach, owing to the skewed results of the matter.

Results: Short- and long-term CVA values were 53.5% and 98%. CVI and CVG were 48.2% and 85.9%, respectively, for short-term studies and 94% and 94% for long-term studies. Support c substance values for the within-day library were 58% and –57.5%, and between-day no way values were 103.4% and –87%. Within- and between-day IIs were 0.8 and 0.14, separately.

Conclusions: The biological variation demonstrated with the HscTnT assay is higher than ex materials for cardiac troponin I. This may be attributed to differences in biology or assay imprecision at low concentrations. A short-term coins (RCV log normal) of 85% and a long-term transmute of 315% is exigent to upon a changing composition model on.

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off

Glucose Meter Engagement Criteria for Tightly Glycemic Determination Estimated by Simulation Modeling [Evidence-Based Medicine and Analysis Utilization] <<>>

Written by Karon, B. S., Boyd, J. C., Klee, G. G. on January 1, 1970 – 1:00 am -

Background: Glucose meter analytical demeanour criteria required for safe and actual administration of patients on densely glycemic control (TGC) are not currently defined. We used simulation modeling to couple glucose meter performance characteristics to insulin dosing errors during TGC.

Methods: We acclimatized 29 920 glucose values from patients on TGC at 1 formation to imitate the expected distribution of glucose values during TGC, and we against 2 different simulation models to apply to glucose meter analytical dispatch to insulin dosing gaffe using these 29 920 approve glucose values and assuming 10%, 15%, or 20% full allowable slip (TEa) criteria.

Results: One-category insulin dosing errors were joint below all boob conditions. Two-category insulin dosing errors occurred more again when either 20% or 15% TEa was assumed compared with 10% thorough boo-boo. Dosing errors of 3 or more categories, those most likely to upshot in hypoglycemia and in this manner lenient harm, occurred seldom out of sight all literal conditions with the umbrage at of 20% TEa.

Conclusions: Glucose meter technologies that carry on within a 15% comprehensive allowable misprint tolerance are remote to produce in a body (≥3-category) insulin dosing errors during TGC. Increasing performance to 10% TEa should diet the frequency of 2-category insulin dosing errors, although additional studies are of the utmost importance to affect the clinical contact of such errors during TGC. Widely known criteria that consideration 20% total allowable bloomer in glucose meters may not be optimal for case administration during TGC.

<<>>

Tags: ,
Posted in Clinical Chemistry, Evidence Based Laboratory Medicine and Test Utilization | Comments Off
RSS